Cancers after HLA-matched related Bone Marrow Transplantation for Aplastic Anemia

We analyzed subsequent cancers in 329 patients with aplastic anemia given HLA-matched related marrow grafts. Median follow-up: 26 (range 1-47) years. Conditioning: cyclophosphamide ± antithymocyte globulin; graft-vs.-host disease (GVHD) prevention: methotrexate ± cyclosporine. The long follow-up and...

Descripción completa

Detalles Bibliográficos
Autores principales: Vo, Phuong, Onstad, Lynn, Flowers, Mary E., Storb, Rainer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8738111/
https://www.ncbi.nlm.nih.gov/pubmed/34657145
http://dx.doi.org/10.1038/s41409-021-01498-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8738111/
https://www.ncbi.nlm.nih.gov/pubmed/34657145
http://dx.doi.org/10.1038/s41409-021-01498-1

Ejemplares similares